Ads
    Related conference
  1. The level of Β-2-microglobulin, albuminuria in patients with chronic heart failure and atrial fibrillation depending on the functional state of the kidneys
  2. Changes of the level of galectin-3, β-2-microglobulin, albuminuria and end glycation products in patients with chronic heart failure and atrial fibrillation under the influence of treatment
  3. PARAMETERS OF THE HEMODYNAMIC AFTER ABLATION ATRIAL FIBRILLATION AND/OR FLUTTER DEPENDING ON THE FUNCTIONAL CLASS OF CHRONIC HEART FAILURE
  4. Frequency of risk factors of cardiovascular diseases and renal functional state in patients with chronic heart failure with atrial fibrillation
  5. FUNCTIONAL CLASSES AND CLINICAL CHARACTERISTICS OF CHRONIC HEART FAILURE IN PATIENTS WITH ATRIAL FIBRILLATION AND/OR FLUTTER AFTER RADIOFREQUENCY ABLATION
  6. FUNCTION CLASS OF CHRONIC HEART FAILURE AND EFFICIENCY OF THERAPY AMIODARONE AND ITS COMBINATION WITH BETA-ADRENOBLOCKERS PERMANENT FORM OF ATRIAL FIBRILLATION AT PATIENTS WITH ARTERIAL HYPERTENSION AND ISCHEMIC HEART DISEASE
  7. Clinical course and risk prediction of permanent atrial fibrillation development in patients with chronic heart failure and mid-range ejection fraction of the left ventricle
  8. Hemodynamics, functional state of endothelium and renal function, platelets depending on the body mass index in patients with chronic heart failure and preserved systolic function
  9. Atrial Fibrillation in Patients after Myocardial Infarction: Association with Changes in Heart Structure, Heart Failure and Age
  10. Peculiarities of pharmacotherapy of chronic heart failure with retained left ventricular efficiency and associated atrial fibrilation depending on the method of heart rhythm control